Skip to main content
Top

10-04-2024 | Metastasis | Case Study

Gamma knife radiosurgery for clival metastasis: case series and systematic review

Authors: Sakibul Huq, Regan M. Shanahan, Samuel Adida, Othman Bin-Alamer, Hussam Abou-Al-Shaar, Ajay Niranjan, Constantinos G. Hadjipanayis, L. Dade Lunsford

Published in: Journal of Neuro-Oncology

Login to get access

Abstract

Purpose

Clival metastatic cancer is rare and has limited literature to guide management. We describe management of clival metastasis with Gamma Knife radiosurgery (GKRS). We augment our findings with a systematic review of all forms of radiation therapy for clival metastasis.

Methods

Records of 14 patients with clival metastasis who underwent GKRS at the University of Pittsburgh Medical Center from 2002 to 2023 were reviewed. Treatment parameters and clinical outcomes were assessed. A systematic review was conducted using evidence-based guidelines.

Results

The average age was 61 years with male predominance (n = 10) and average follow-up of 12.4 months. The most common primary cancers were prostate (n = 3) and lung (n = 3). The average time from cancer diagnosis to clival metastasis was 34 months. The most common presenting symptoms were headache (n = 9) and diplopia (n = 7). Five patients presented with abducens nerve palsies, and two presented with oculomotor nerve palsies. The median tumor volume was 9.3 cc, and the median margin dose was 15 Gy. Eleven patients achieved tumor control after one procedure, and three with progression obtained tumor control after repeat GKRS. One patient recovered abducens nerve function. The median survival from cancer diagnosis and GKRS were 49.7 and 15.3 months, respectively. The cause of death was progression of systemic cancer in six patients, clival metastasis in one, and unknown in four. The systematic review included 31 studies with heterogeneous descriptions of treatment and outcomes.

Conclusion

Clival metastasis is rare and associated with poor prognosis. GKRS is a safe, effective treatment for clival metastasis.
Appendix
Available only for authorised users
Literature
4.
go back to reference Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, Chou R, Glanville J, Grimshaw JM, Hróbjartsson A, Lalu MM, Li T, Loder EW, Mayo-Wilson E, McDonald S, McGuinness LA, Stewart LA, Thomas J, Tricco AC, Welch VA, Whiting P, Moher D (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71. https://doi.org/10.1136/bmj.n71CrossRefPubMedPubMedCentral Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, Chou R, Glanville J, Grimshaw JM, Hróbjartsson A, Lalu MM, Li T, Loder EW, Mayo-Wilson E, McDonald S, McGuinness LA, Stewart LA, Thomas J, Tricco AC, Welch VA, Whiting P, Moher D (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71. https://​doi.​org/​10.​1136/​bmj.​n71CrossRefPubMedPubMedCentral
6.
go back to reference Agha RA, Sohrabi C, Mathew G, Franchi T, Kerwan A, O’Neill N, Thoma A, Beamish AJ, Noureldin A, Rao A, Vasudevan B, Challacombe B, Perakath B, Kirshtein B, Ekser B, Pramesh CS, Laskin DM, Machado-Aranda D, Pagano D, Roy G, Kadioglu H, Nixon IJ, Mukhejree I, McCaul JA, Chi-Yong Ngu J, Albrecht J, Rivas JG, Raveendran K, Derbyshire L, Ather MH, Thorat MA, Valmasoni M, Bashashati M, Chalkoo M, Teo NZ, Raison N, Muensterer OJ, Bradley PJ, Goel P, Pai PS, Afifi RY, Rosin RD, Coppola R, Klappenbach R, Wynn R, Surani S, Giordano S, Massarut S, Raja SG, Basu S, Enam SA, Manning TG, Cross T, Karanth VKL, Mei Z (2020) The PROCESS 2020 Guideline: updating Consensus Preferred reporting of CasE series in surgery (PROCESS) guidelines. Int J Surg 84:231–235. https://doi.org/10.1016/j.ijsu.2020.11.005CrossRefPubMed Agha RA, Sohrabi C, Mathew G, Franchi T, Kerwan A, O’Neill N, Thoma A, Beamish AJ, Noureldin A, Rao A, Vasudevan B, Challacombe B, Perakath B, Kirshtein B, Ekser B, Pramesh CS, Laskin DM, Machado-Aranda D, Pagano D, Roy G, Kadioglu H, Nixon IJ, Mukhejree I, McCaul JA, Chi-Yong Ngu J, Albrecht J, Rivas JG, Raveendran K, Derbyshire L, Ather MH, Thorat MA, Valmasoni M, Bashashati M, Chalkoo M, Teo NZ, Raison N, Muensterer OJ, Bradley PJ, Goel P, Pai PS, Afifi RY, Rosin RD, Coppola R, Klappenbach R, Wynn R, Surani S, Giordano S, Massarut S, Raja SG, Basu S, Enam SA, Manning TG, Cross T, Karanth VKL, Mei Z (2020) The PROCESS 2020 Guideline: updating Consensus Preferred reporting of CasE series in surgery (PROCESS) guidelines. Int J Surg 84:231–235. https://​doi.​org/​10.​1016/​j.​ijsu.​2020.​11.​005CrossRefPubMed
23.
go back to reference Machío Castelló M, Escobar Montatixe D, Cenjor Español C, Villacampa Aubá JM, Montoya Bordón J, Carias Calix R, Sáez Pinel R (2017) Incomplete cavernous sinus syndrome as the initial manifestation of a previously undetected metastatic prostate adenocarcinoma. Head Neck 39:E77–e80. https://doi.org/10.1002/hed.24808CrossRefPubMed Machío Castelló M, Escobar Montatixe D, Cenjor Español C, Villacampa Aubá JM, Montoya Bordón J, Carias Calix R, Sáez Pinel R (2017) Incomplete cavernous sinus syndrome as the initial manifestation of a previously undetected metastatic prostate adenocarcinoma. Head Neck 39:E77–e80. https://​doi.​org/​10.​1002/​hed.​24808CrossRefPubMed
25.
go back to reference Ng ES, Tan SH, Ling WH, Venkatesh SK, Wong CI (2011) Ophthalmoplegia in a patient with breast cancer. Ann Acad Med Singap 40:507–509CrossRefPubMed Ng ES, Tan SH, Ling WH, Venkatesh SK, Wong CI (2011) Ophthalmoplegia in a patient with breast cancer. Ann Acad Med Singap 40:507–509CrossRefPubMed
Metadata
Title
Gamma knife radiosurgery for clival metastasis: case series and systematic review
Authors
Sakibul Huq
Regan M. Shanahan
Samuel Adida
Othman Bin-Alamer
Hussam Abou-Al-Shaar
Ajay Niranjan
Constantinos G. Hadjipanayis
L. Dade Lunsford
Publication date
10-04-2024
Publisher
Springer US
Published in
Journal of Neuro-Oncology
Print ISSN: 0167-594X
Electronic ISSN: 1573-7373
DOI
https://doi.org/10.1007/s11060-024-04648-9